Monogram (NASDAQ:MGRM) announced it had received an Additional Information Request (“AIR”) from the U.S. Food and Drug Administration (“FDA”) on September 30, 2024, regarding its 510(k ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback